Production of platelet-activating factor in patients with sepsis-associated acute renal failure

Nephrology Dialysis Transplantation

Volumn 14, Issue 5, 1999, Pages 1150-1157

  Mariano, Filippo ^a   Guida, Gianenrico ^b   Donati, Donato ^c   Tetta, Ciro ^d   Cavalli, Pier Luigi ^a   Verzetti, Giuseppe ^b   Piccoli, Giuseppe ^e   Camussi, Giovanni ^e,f  

^a Department of NephroUrology   (Italy)

^b Azienda Ospedaliera   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d Cyberonics Inc   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute renal failure; Cytokines; Humans; Platelet activating factor; Septic shock

Indexed keywords

CREATININE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HEART RATE; HUMAN; KIDNEY FUNCTION; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS; THROMBOCYTE COUNT; URINARY EXCRETION; URINE LEVEL;

AGED; AGED, 80 AND OVER; ANIMALS; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PLATELET ACTIVATING FACTOR; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032894586     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.5.1150     Document Type: Article

References (26)

1. Tolins JP, Vercellotti GM, Wilkowske M, Ha B, Jacob HS, Raij L. Role of platelet activating factor in endotoxemic acute renal failure in the male rat. J Lab Clin Med 1989; 113: 316-324
2. Wang J, Dunn MJ. Platelet-activating factor mediates endotoxin-induced acute renal failure insufficiency in rats. Am J Physiol 1987; 253: F1283-1289
3. Schlondorff D, Goldwasser P, Neuwirth R, Satriano A, Clay KL. Production of Platelet-activating factor in glomeruli and cultured glomerular mesangial cells. Am J Physiol 1986; 250: F1123-1127
4. Camussi G, Mariano F, Biancone L et al. Lipopolysaccharide Binding Protein and CD14 modulate the synthesis of platelet activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 1995; 255: 316-324
5. Camussi G, Montrucchio G, Dominioni L, Dionigi R. Septic shock-the unravelling of molecular mechanisms. Nephrol Dial Transplant 1995; 10: 1808-1813
6. Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor Necrosis Factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthetize and release platelet-activating factor. J Exp Med 1987; 166: 1390-1396
7. Valone FH, Epstein LB. Biphasic Platelet-activating factor synthesis by human monocytes stimulated with IL-1 beta, tumor necrosis factor or IFN-gamma. J Immunol 1988; 141: 3945-3950
8. Lopez Diez F, Nieto ML, Fernandez-Gallardo S, Gijon MA, Sanchez Crespo M. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia. J Clin Invest 1989; 83: 1733-1740
9. 2 in patients with septic shock and trauma. Intensive Care Med 1994; 20: 555-561
10. Ono S, Mochizuki H, Tamakuma A. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery. Am J Surg 1996; 171: 409-415
11. Graham RM, Stephens CJ, Silvester W, Leong LL, Sturm MJ, Taylor RR. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med 1994; 22: 204-212
12. Alloatti G, Montrucchio G, Mariano F et al. Effect of platelet-activating factor (PAF) on human cardiac muscle. Int Arch Allergy Appl Immunol 1986; 79: 108-112
13. Scherf H, Nies AS, Schwertschlag U, Hughes M, Gerber JG. Hemodynamic effects of platelet activating factor in the dog kidney in vivo. Hypertension 1986; 8: 737-741
14. The ACCP/SCCM Consensus Conference Committee: Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-1655
15. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985; 202: 685-693
17. Cohen JJ, Black AJ, Wertheim SI. Directs effects of endotoxin on the function of isolated perfused rat kidney. Kidney Int 1990; 37: 1219-1226
18. Xia Y, Feng L, Yoshimura T, Wilson CB. LPS-induced MCP-1, IL-1-beta and TNF-alpha mRNA expression in isolated erythrocyte-perfused rat kidney. Am J Physiol 1993; 264: F774-780
19. Schlondorff D, Nelson PJ, Luckow B, Banas B. Chemokines and renal disease. Kidney Int 1997; 51: 610-621
20. Caserta C, Bussolati B, David S, Camussi G, Cambi V. Serum containing soluble CD14 modulates lypopolysaccharide-induced activation of cultured human tubular cells (Abstract). Nephrol Dial Transplant 1996; 11: A14
21. Linas SL, Whittenburg D, Repine JE. Role of neutrophil derived oxidants and elastase in lipopolysaccharide-mediated renal injury. Kidney Int 1991; 39: 618-623
22. Camussi G, Mariano F, Biancone L, Montrucchio G, Vercellone A. Effect of cytokines on the cytoskeleton of resident glomerular cells. Kidney Int 1993; 43 [Suppl 39]: S32-36
23. Jacobson SH, Hylander B, Wretlind B, Brauner A. Interleukin-6 and Interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal functions. Nephron 1994; 67: 172-179
24. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis. Ann Intern Med 1993; 119: 771-778
25. Rogy MA, Oldenburg HSA, Coyle S, Trousdale R, Moldawer LL, Lowry SF. Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg 1996; 83: 396-400
26. Sugimoto T, Tsuchinochi H, McGregor CG, Mutoh H, Shimizu H, Kurachi K. Molecular cloning and characterization of the platelet activating factor receptor gene expressed in the human heart. Biochem Biophys Res Commun 1992; 189: 617-624